People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nevro Corp | — | Biotechnology | Series C | $78.6M | $2.4B | 2011 |
| Cardionomic, Inc. | — | Other Health Care | Series B | $51.7M | $76.3M | 2015 |
| Rotation Medical Inc | — | Other Health Care | Series B | $51.1M | $177.2M | 2009 |
| Synaptive Medical Inc. | — | Biotechnology | Series A | $34.8M | $180.5M | 2017 |
Michael DeMane at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael DeMane on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali Behbahani | 2 | 17 |
| Tara Butler | 1 | 12 |
| John Nehra | 1 | 11 |
| Fouad Azzam | 1 | 8 |
| Kevin Sidow | 1 | 7 |
| John Deedrick | 1 | 7 |
| Brian Farley | 1 | 5 |
| Scott Weiner | 1 | 4 |
| Vincent Kim | 1 | 4 |
| Doug Janzen | 1 | 4 |
| Jon Tremmel | 1 | 3 |
| Karen Shanahan | 1 | 3 |
| Ali Jay Behbahani | 1 | 3 |
| Andrew Galligan | 1 | 3 |
| Konstantinos Alataris | 1 | 3 |
| Andrew Prozes | 1 | 3 |
| Akhil Saklecha | 1 | 3 |
| Albert Graf | 1 | 2 |
| Mark B Knudson | 1 | 2 |
| William Patrick Ryan | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.